RP
RGEN icon

Riverbridge Partners’s Repligen RGEN Stock Holding History

Riverbridge Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Sell
172,507
-85,969
-33% -$10.6M 0.66% 48
2026
Q1 		$30.5M Sell
258,476
-54,889
-18% -$7.67M 0.75% 48
2025
Q4 		$51.3M Sell
313,365
-30,070
-9% -$4.71M 0.96% 34
2025
Q3 		$45.9M Sell
343,435
-24,644
-7% -$2.99M 0.77% 43
2025
Q2 		$45.8M Sell
368,079
-54,023
-13% -$6.87M 0.74% 48
2025
Q1 		$53.7M Sell
422,102
-32,996
-7% -$5.08M 0.86% 40
2024
Q4 		$65.5M Sell
455,098
-45,878
-9% -$6.58M 0.89% 42
2024
Q3 		$74.6M Sell
500,976
-26,896
-5% -$3.86M 1% 38
2024
Q2 		$66.5M Buy
527,872
+82,704
+19% +$13M 0.9% 42
2024
Q1 		$81.9M Sell
445,168
-5,771
-1% -$1.1M 1% 40
2023
Q4 		$81.1M Sell
450,939
-8,822
-2% -$1.37M 1.01% 37
2023
Q3 		$73.1M Buy
459,761
+244,965
+114% +$40M 1% 36
2023
Q2 		$30.4M Buy
+214,796
New +$34.4M 0.38% 77

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Riverbridge Partners's RGEN Position: Q2 2026 in Review

Riverbridge Partners reduced its Repligen (RGEN) stake by 33% in Q2 2026, selling an estimated $10.6M and leaving 172,507 shares worth $23.5M. The position accounts for 0.66% of the portfolio, ranked #48.

Riverbridge Partners first reported a position in RGEN in Q2 2023 and has held it in 13 quarters since. The position peaked at $81.9M in Q1 2024. 480 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Riverbridge Partners held 172,507 shares of Repligen worth $23.5M as of Q2 2026.
  • Riverbridge Partners sold 85,969 Repligen shares in Q2 2026, an estimated $10.6M.
  • Repligen made up 0.66% of Riverbridge Partners's portfolio in Q2 2026, its #48 holding.
  • Riverbridge Partners first reported a position in Repligen in Q2 2023 and has held it in 13 quarters since.
  • Riverbridge Partners's Repligen position peaked at $81.9M in Q1 2024.
  • 480 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.